Cite
Human Papillomavirus Vaccination and Premature Ovarian Failure: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System.
MLA
Tatang, Collins, et al. “Human Papillomavirus Vaccination and Premature Ovarian Failure: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System.” Drugs - Real World Outcomes, vol. 9, no. 1, Mar. 2022, pp. 79–90. EBSCOhost, https://doi.org/10.1007/s40801-021-00271-6.
APA
Tatang, C., Arredondo Bisonó, T., Bergamasco, A., Salvo, F., Costa Clemens, S. A., & Moride, Y. (2022). Human Papillomavirus Vaccination and Premature Ovarian Failure: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System. Drugs - Real World Outcomes, 9(1), 79–90. https://doi.org/10.1007/s40801-021-00271-6
Chicago
Tatang, Collins, Teigna Arredondo Bisonó, Aurore Bergamasco, Francesco Salvo, Sue Ann Costa Clemens, and Yola Moride. 2022. “Human Papillomavirus Vaccination and Premature Ovarian Failure: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System.” Drugs - Real World Outcomes 9 (1): 79–90. doi:10.1007/s40801-021-00271-6.